Funder: National Institutes of Health
Due Dates: June 2, 2018 (Letter of Intent) | July 2, 2018 (Full Application, due by 5:00 PM local time)
Funding Amounts: Up to $3.1 million per year (direct costs); maximum project period 7 years; one award anticipated.
Summary: Supports longitudinal cohort studies to determine how initial and repeated influenza exposures in infants shape future immunity, informing universal influenza vaccine design.
Key Information: Clinical trials are not allowed; only mechanistic and observational studies permitted.